Your browser doesn't support javascript.
loading
Advances in Development of mRNA-Based Therapeutics.
Huang, Lei; Zhang, Luyao; Li, Weiwei; Li, Shiqiang; Wen, Jianguo; Li, Hangwen; Liu, Zhongmin.
Afiliação
  • Huang L; Stemirna Therapeutics Inc, Shanghai, 201206, China.
  • Zhang L; Stemirna Therapeutics Inc, Shanghai, 201206, China.
  • Li W; Stemirna Therapeutics Inc, Shanghai, 201206, China.
  • Li S; Stemirna Therapeutics Inc, Shanghai, 201206, China.
  • Wen J; Stemirna Therapeutics Inc, Shanghai, 201206, China.
  • Li H; Stemirna Therapeutics Inc, Shanghai, 201206, China. lihangwen@stemirna.com.
  • Liu Z; Shanghai East Hospital, Shanghai, 200120, China.
Curr Top Microbiol Immunol ; 440: 147-166, 2022.
Article em En | MEDLINE | ID: mdl-32683507
Recently, mRNA-based therapeutics have been greatly boosted since the development of novel technologies of both mRNA synthesis and delivery system. Promising results were showed in both preclinical and clinical studies in the field of cancer vaccine, tumor immunotherapy, infectious disease prevention and protein replacement therapy. Recent advancements in clinical trials also encouraged scientists to attempt new applications of mRNA therapy such as gene editing and cell programming. These studies bring mRNA therapeutics closer to real-world application. Herein, we provide an overview of recent advances in mRNA-based therapeutics.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Imunoterapia Idioma: En Revista: Curr Top Microbiol Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Imunoterapia Idioma: En Revista: Curr Top Microbiol Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China